Giuseppe Saltalamacchia
Milan, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 28 publications
From intravenous to subcutaneous pertuzumab/trastuzumab in breast cancer: Clinical and pharmacoeconomic drivers and barriers to switching.
Journal: Tumori
Published: December 15, 2025
Pretreatment tumor infiltrating lymphocytes and outcome in patients with HR+/HER2- advanced breast cancer treated with CDK4/6 inhibitors.
Journal: Scientific reports
Published: November 07, 2025
Real-world patterns of post-progression treatment and outcomes in patients with HR+/HER2- advanced breast cancer treated with CDK4/6 inhibitors.
Journal: The oncologist
Published: June 16, 2025
Real-world patterns of post-progression treatment and outcomes in patients with HR+/HER2- advanced breast cancer treated with CDK4/6 inhibitors.
Journal: The oncologist
Published: June 16, 2025
Beyond failure of endocrine-based therapies in HR+/HER2 negative advanced breast cancer: What before chemotherapy? A glimpse into the future.
Journal: Critical reviews in oncology/hematology
Published: November 04, 2024
Incorporating radiomic MRI models for presurgical response assessment in patients with early breast cancer undergoing neoadjuvant systemic therapy: Collaborative insights from breast oncologists and radiologists.
Journal: Critical reviews in oncology/hematology
Published: October 03, 2024
Pre-existing and emerging immune-mediated diseases in patients with breast cancer undergoing cyclin-dependent kinases 4/6 inhibitors and endocrine therapy.
Journal: The oncologist
Published: September 30, 2024
Digital innovations in breast cancer care: exploring the potential and challenges of digital therapeutics and clinical decision support systems.
Journal: Digital health
Published: January 20, 2024
Charting the Course in Sequencing Antibody-Drug Conjugates in Breast Cancer.
Journal: Biomedicines
Published: December 15, 2023
Last Updated: 09/26/2026